jvkohl
04-18-2006, 12:22 PM
Kaminski RM, Marini H, Won-Joo K, and Rogawski MA (2005) Anticonvulsant activity of androsterone and etiocholanolone. Epilepsia 46:819–827.
"Androstanediol is a positive modulator of
GABAA receptors (Frye et al., 1996) with potent anxiolytic
and anticonvulsant activity (Frye and Reed, 1998; Reddy,
2004a,b); recently, we confirmed that androsterone has similar
systemic activities (Kaminski et al., 2005)."
An anxiolytic is any drug or therapy used in the treatment of anxiety disorders. I am following up on this recent report to determine whether GABA interaction might be the means by which androsterone (as used in SoE for men) might indicate reduced anxiety in the wearer as well as reduce anxiety in people (especially women) who are exposed to it.
It's somewhat satisfying to see the Forum members indicate this effect, but more satisfying to find scientific support for the effect.
JVK
Discussion on this topic can be found by clicking here. (http://www.pherolibrary.com/forum/showthread.php?t=15853)
"Androstanediol is a positive modulator of
GABAA receptors (Frye et al., 1996) with potent anxiolytic
and anticonvulsant activity (Frye and Reed, 1998; Reddy,
2004a,b); recently, we confirmed that androsterone has similar
systemic activities (Kaminski et al., 2005)."
An anxiolytic is any drug or therapy used in the treatment of anxiety disorders. I am following up on this recent report to determine whether GABA interaction might be the means by which androsterone (as used in SoE for men) might indicate reduced anxiety in the wearer as well as reduce anxiety in people (especially women) who are exposed to it.
It's somewhat satisfying to see the Forum members indicate this effect, but more satisfying to find scientific support for the effect.
JVK
Discussion on this topic can be found by clicking here. (http://www.pherolibrary.com/forum/showthread.php?t=15853)